ÉVRY-COURCOURONNES, France--(BUSINESS WIRE)--Abolis Biotechnologies, a company specializing in industrial solutions using microorganisms, today announced that it has entered into a strategic partnership with EUROAPI, one of the world's leading producers of active pharmaceutical ingredients, for the development of microbial strains for the synthesis of key intermediates and 20 active ingredients, particularly from the corticosteroid family. This industrial partnership is part of the « Important. ...